JPMA and International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) co-hosted the symposium Report on "G7 Hiroshima Summit: Recommendations for the Health Agenda -Lessons Learned from COVID-19 to Facilitate Progress Toward SDG 3: A Roadmap for Action~.
JPMA and IFPMA co-hosted a symposium entitled "Recommendations for the G7 Hiroshima Summit Health Agenda: Leveraging Lessons Learned from COVID-19 to Promote Progress toward SDG3: A Roadmap for Action" on Friday, May 12, 2023, from 16:30 to 18:30. The conference was held on Friday, May 12, 2023, from 16:30 to 18:30.
Inviting leading figures in health policy and system building in Japan and internationally, we aimed to deepen discussion on international health challenges and solutions for the post-coronary era, and to disseminate the contents of the conference widely.
The symposium is also introduced on the website of IFPMA, the co-sponsor of the symposium.
Proposals for the G7 Hiroshima Summit Health Agenda - IFPMA
Program
Agenda Overview
Article Ads
G7 Hiroshima Summit: "Recommendations for the Health Agenda"
Newspaper & Magazine Advertisement | JPMA's video content and advertisement | Japan Pharmaceutical Manufacturers Association (jpma.or.jp)
A collected article about this symposium was published in the Tokyo edition of the Yomiuri Shimbun morning edition on June 16, 2023.
Subsequent editions of the Osaka, Nagasaki, and Hiroshima editions of the Yomiuri Shimbun will follow in succession during the month of June.